Literature DB >> 8819121

Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells.

M Benathan1.   

Abstract

The catechol 5-S-cysteinyldopa (5-S-CD) is produced in large amounts in metastatic malignant melanoma. To further understand the mechanism of formation of 5-S-CD, we investigated the effects of thiol modulating agents and melanin precursors on human melanoma cells. Under standard culture conditions (0.1 mM cystine), the cell levels of 5-S-CD were highly correlated with the degree of melanization and the dopa oxidase activity of the four cell lines investigated (Me8, JUSO, GLL19, Swift). Inhibition of glutathione (GSH) biosynthesis with buthionine sulphoximine did not affect 5-S-CD levels in the low melanotic GL 19 cells. In contrast, the highly pigmented Swift cells showed a strong increase in the cell levels of cystine (CysH) and 5-S-CD. When the cystine concentration of the growth medium was increased to 0.2 mM, a similar situation of 5-S-CD synthesis caused by an increase in intracellular CysH levels was observed in the Swift cells. The GLL19 cells showed enhanced 5-S-CD formation in the presence of 0.1 mM L-dopa. This effect was associated with a fourfold increase in dopa oxidase activity. Our data clearly indicate that 5-S-CD is formed in human melanoma cells by a tyrosinase-dependent mechanism involving the addition of CysH to dopaquinone. Based on the enhancing effect of buthionine sulphoximine on 5-S-CD formation, it is proposed that GSH is not directly implicated in 5-S-CD formation, but regulates CysH levels via the enzyme gamma-glutamylcysteine synthetase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8819121     DOI: 10.1097/00008390-199606000-00001

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  4 in total

1.  Serum levels of S-100 protein and 5-S-cysteinyldopa as markers of melanoma progression.

Authors:  T Bánfalvi; K Gilde; M Boldizsár; T Kremmer; S Ottó
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

2.  Malignant melanoma of the male urethra with increased 5-S-cysteinyldopa: A case report.

Authors:  Yusuke Aoki; Takahiko Soma; Yuki Nakamura; Naotaka Fukui; Yasuyuki Sakai; Yukio Kageyama
Journal:  IJU Case Rep       Date:  2019-06-11

3.  Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III-IV malignant melanoma.

Authors:  Teodóra Bánfalvi; Mariann Boldizsár; Maria Gergye; Katalin Gilde; Tibor Kremmer; Szabolcs Ottó
Journal:  Pathol Oncol Res       Date:  2003-01-06       Impact factor: 3.201

Review 4.  Chemical and biochemical control of skin pigmentation with special emphasis on mixed melanogenesis.

Authors:  Kazumasa Wakamatsu; Jonathan H Zippin; Shosuke Ito
Journal:  Pigment Cell Melanoma Res       Date:  2021-03-22       Impact factor: 4.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.